Acute Porphyria Drugs

C07AA07 - Sotalol

Not porphyrinogenic
NP

Rationale
Beta-blocker, not metabolised. Occasional clinical observation of tolerance. Two references state non-porphyrinogenicity.
Chemical description
Water-soluble beta-receptor blocking substance. Excreted unchanged in urine.
Personal communication
Thunell, patient reports (n=3): tolerated.
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes C07A / C07AA or go back.
References
# Citation details PubMed ID
Porphyria Drug Lists
1. French List
Centre Français des Porphyries
2. EPI List
European Porphyria Initiative No longer maintained
3. South African List
Porphyria South Africa No longer maintained
Tradenames

Sotalol Sotalex · Sotalol Sotalex · Sotalol Sotalol · Sotapor Sotalex Rytmobeta · Sotalex · Sotalolo Darob · Sotagamma · Sotalol Sotalol Beta-Cardone · Sotacor · Sotalol Sotalol Sotacor · Sotalol Sotalol · Sotalol-umip Biosotal · Sotahexal · Sotalol Sotacor · Sotahexal · Sotalol SotaHexal · Sotalol Sotalol Sotalex Sotalol Sotacor · Sotalol Sotagamma Sotahexal Darob Darob Darob · Loritmik · Sotalolijev Sotahexal Sotalol
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙